Form 8-K - Current report:
SEC Accession No. 0001641172-25-012288
Filing Date
2025-05-23
Accepted
2025-05-23 16:30:15
Documents
15
Period of Report
2024-12-29
Items
Item 1.03: Bankruptcy or Receivership
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 4.01: Changes in Registrant's Certifying Accountant
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 66269
2 EX-16.1 ex16-1.htm EX-16.1 900
3 GRAPHIC ex16-1_001.jpg GRAPHIC 143440
  Complete submission text file 0001641172-25-012288.txt   430660

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE arth-20241229.xsd EX-101.SCH 3038
5 XBRL LABEL FILE arth-20241229_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE arth-20241229_pre.xml EX-101.PRE 22374
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3354
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

EIN.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 25982860
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)